Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Genetics
|
August 30, 2008
The pleiotropic phenotype of Apc mutations in the mouse: allele specificity and effects of the genetic background
Richard B Halberg, Xiaodi Chen, James M Amos-Landgraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2006
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741
Kimmie Ng, Daniel J Sargent, Richard M Goldberg, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 11, 2014
Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors
Gregory D Kennedy, Manabu Nukaya, Susan M Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841
Jan Franko, Qian Shi, Charles D Goldman, et al.
Cancer Chemotherapy and Pharmacology
|
February 27, 2015
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
Herbert I Hurwitz, David C Smith, Henry C Pitot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Cancer
|
December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma
Ravi D Rao, Shernan G Holtan, James N Ingle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2023
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors
Henry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Genetics
|
August 30, 2008
The pleiotropic phenotype of Apc mutations in the mouse: allele specificity and effects of the genetic background
Richard B Halberg, Xiaodi Chen, James M Amos-Landgraf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2006
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2011
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741
Kimmie Ng, Daniel J Sargent, Richard M Goldberg, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 11, 2014
Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors
Gregory D Kennedy, Manabu Nukaya, Susan M Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841
Jan Franko, Qian Shi, Charles D Goldman, et al.
Cancer Chemotherapy and Pharmacology
|
February 27, 2015
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
Herbert I Hurwitz, David C Smith, Henry C Pitot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Cancer
|
December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma
Ravi D Rao, Shernan G Holtan, James N Ingle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 28, 2023
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors
Henry C Pitot, Joel M Reid, Jeff A Sloan, et al.
Page
of 9